Safety Shot, Inc. (NASDAQ:SHOT) Sees Large Decline in Short Interest

Safety Shot, Inc. (NASDAQ:SHOT) was the recipient of a large decline in short interest during the month of January. As of January 15th, there was short interest totalling 3,300,000 shares, a decline of 13.4% from the December 31st total of 3,810,000 shares. Currently, 6.4% of the company’s stock are short sold. Based on an average daily volume of 898,700 shares, the days-to-cover ratio is currently 3.7 days.

Safety Shot Stock Down 7.8 %

NASDAQ:SHOT opened at $0.47 on Monday. Safety Shot has a twelve month low of $0.45 and a twelve month high of $4.05. The stock’s 50 day moving average price is $0.72 and its two-hundred day moving average price is $0.92.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. CreativeOne Wealth LLC acquired a new position in shares of Safety Shot during the 3rd quarter worth approximately $27,000. Tyler Stone Wealth Management boosted its stake in Safety Shot by 100.0% in the 3rd quarter. Tyler Stone Wealth Management now owns 34,200 shares of the company’s stock valued at $42,000 after purchasing an additional 17,100 shares during the period. Total Investment Management Inc. bought a new stake in Safety Shot in the 3rd quarter valued at $49,000. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new stake in shares of Safety Shot during the 4th quarter worth $74,000. Finally, State Street Corp grew its stake in Safety Shot by 40.5% during the third quarter. State Street Corp now owns 146,100 shares of the company’s stock worth $178,000 after buying an additional 42,100 shares in the last quarter. 12.55% of the stock is owned by institutional investors and hedge funds.

Safety Shot Company Profile

Safety Shot, Inc, a wellness and functional beverage company, researches and develops over-the-counter products and intellectual property. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It also develops Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; and NoStingz, a jellyfish sting prevention sunscreen.